These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31171832)

  • 1. Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer.
    Barel F; Cariou M; Saliou P; Kermarrec T; Auffret A; Samaison L; Bourhis A; Badic B; Jézéquel J; Cholet F; Bail JP; Marcorelles P; Nousbaum JB; Robaszkiewicz M; Doucet L; Uguen A
    Sci Rep; 2019 Jun; 9(1):8342. PubMed ID: 31171832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses.
    Barel F; Auffret A; Cariou M; Kermarrec T; Samaison L; Bourhis A; Badic B; Jézéquel J; Cholet F; Bail JP; Marcorelles P; Nousbaum JB; Robaszkiewicz M; Doucet L; Uguen A
    Pathology; 2019 Jan; 51(1):46-54. PubMed ID: 30477880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
    Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
    Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection.
    Martínez Vila C; Oliveres Montero de Novoa H; Martínez-Bauer E; Serra-Aracil X; Mora L; Casalots-Casado A; Macías-Declara I; Pericay C
    Int J Colorectal Dis; 2020 May; 35(5):921-927. PubMed ID: 32146501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of salvage surgery for colorectal cancer initially treated by upfront endoscopic therapy.
    Nozawa H; Ishihara S; Fujishiro M; Kodashima S; Ohtani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Kazama S; Sunami E; Kitayama J; Watanabe T
    Surgery; 2016 Mar; 159(3):713-20. PubMed ID: 26477474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1 colorectal cancer: poor histological grading is predictive of lymph-node metastases.
    Caputo D; Caricato M; La Vaccara V; Taffon C; Capolupo GT; Coppola R
    Int J Surg; 2014; 12(3):209-12. PubMed ID: 24378911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.
    Glasgow SC; Bleier JI; Burgart LJ; Finne CO; Lowry AC
    J Gastrointest Surg; 2012 May; 16(5):1019-28. PubMed ID: 22258880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological factors predicting loco-regional lymph node metastasis in early invasive colorectal adenocarcinoma pT1].
    Machado I; Valera-Alberni M; Martínez de Juan F; López-Guerrero JA; García Fadrique A; Cruz J; Martínez Lapiedra C; de Alcantara FM; Yaya R; Campos J; Fernández-Martos C; Estevan R
    Gastroenterol Hepatol; 2016 Jan; 39(1):1-8. PubMed ID: 26049903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis.
    Cappellesso R; Luchini C; Veronese N; Lo Mele M; Rosa-Rizzotto E; Guido E; De Lazzari F; Pilati P; Farinati F; Realdon S; Solmi M; Fassan M; Rugge M
    Hum Pathol; 2017 Jul; 65():62-70. PubMed ID: 28438617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node.
    Kudo SE; Ichimasa K; Villard B; Mori Y; Misawa M; Saito S; Hotta K; Saito Y; Matsuda T; Yamada K; Mitani T; Ohtsuka K; Chino A; Ide D; Imai K; Kishida Y; Nakamura K; Saiki Y; Tanaka M; Hoteya S; Yamashita S; Kinugasa Y; Fukuda M; Kudo T; Miyachi H; Ishida F; Itoh H; Oda M; Mori K
    Gastroenterology; 2021 Mar; 160(4):1075-1084.e2. PubMed ID: 32979355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological evaluation of colorectal cancer specimens: advanced and early lesions.
    Resch A; Schneider NI; Langner C
    Cesk Patol; 2015; 51(1):12-22. PubMed ID: 25671357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastases and recurrence in pT1 colorectal cancer: Prediction with the International Budding Consortium Score-A retrospective, multi-centric study.
    Dawson H; Bokhorst JM; Studer L; Vieth M; Oguz Erdogan AS; Kus Öztürk S; Kirsch R; Brockmoeller S; Cathomas G; Buslei R; Fink D; Roumet M; Zlobec I; van der Laak J; Nagtegaal ID; Lugli A
    United European Gastroenterol J; 2024 Apr; 12(3):299-308. PubMed ID: 38193866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Histologic Features in Colorectal Nonpedunculated Malignant Polyps With Nodal Metastasis.
    Patel N; Vyas M; Celli R; Jain D; Zhang X
    Am J Surg Pathol; 2020 Feb; 44(2):241-246. PubMed ID: 31498179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Lymph Node Metastases in pT1 Colorectal Cancer Differ According to Tumor Morphology: A Nationwide Cohort Study.
    Ebbehøj AL; Smith HG; Jørgensen LN; Krarup PM
    Ann Surg; 2023 Jan; 277(1):127-135. PubMed ID: 35984010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients.
    Gagnière J; Dupré A; Chabaud S; Peyrat P; Meeus P; Rivoire M
    Eur J Surg Oncol; 2015 Jun; 41(6):731-7. PubMed ID: 25899983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria.
    Hanada Y; Choi AY; Hwang JH; Draganov PV; Khanna L; Sethi A; Bartel MJ; Goel N; Abe S; De Latour RA; Park K; Melis M; Newman E; Hatzaras I; Reddy SS; Farma JM; Liu X; Schlachterman A; Kresak J; Trapp G; Ansari N; Schrope B; Lee JY; Dhall D; Lo S; Jamil LH; Burch M; Gaddam S; Gong Y; Del Portillo A; Tomizawa Y; Truong CD; Brewer Gutierrez OI; Montgomery E; Johnston FM; Duncan M; Canto M; Ahuja N; Lennon AM; Ngamruengphong S
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1763-1769. PubMed ID: 30471457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.
    Mescoli C; Albertoni L; Pucciarelli S; Giacomelli L; Russo VM; Fassan M; Nitti D; Rugge M
    J Clin Oncol; 2012 Mar; 30(9):965-71. PubMed ID: 22355061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.